Document ID: chunk:federal_register_of_legislation:F2023L01747:schedule:1:p15
Version: federal_register_of_legislation:F2023L01747
Segment Type: schedule
Provision Reference: sch 1 (pt 15/31)
Character Range: 47903–51118

in the order indicated, and in alphabetical order for the column headed "Brand":
            Ramipril Viatris  AL  MP NP        30  5  30

     [86]               Schedule 1, Part 1, entry for Ramipril in the form Tablet 1.25 mg [Maximum Quantity: 60; Number of Repeats: 5]
     insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
            Ramipril Viatris  AL  MP NP     P14238  60  5  30

     [87]               Schedule 1, Part 1, entry for Sitagliptin with metformin in the form Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride
     insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         a  SITAGLIPTIN/METFORMIN 50/500 SUN  RA  MP  C6333 C6334 C6344 C6443 C7507 C7530     56  5  56
                                                  NP  C6333 C6334 C6344 C6443 C7530           56  5  56

     [88]               Schedule 1, Part 1, entry for Sitagliptin with metformin in the form Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride
     insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         a  SITAGLIPTIN/METFORMIN 50/850 SUN  RA  MP  C6333 C6334 C6344 C6443 C7507 C7530     56  5  56
                                                  NP  C6333 C6334 C6344 C6443 C7530           56  5  56

     [89]               Schedule 1, Part 1, entry for Sitagliptin with metformin in the form Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride
     insert in the columns in the order indicated, and in alphabetical order for the column headed "Brand":
         a  SITAGLIPTIN/METFORMIN 50/1000 SUN  RA  MP  C6333 C6334 C6344 C6443 C7507 C7530     56  5  56
                                                   NP  C6333 C6334 C6344 C6443 C7530           56  5  56

     [90]               Schedule 1, Part 1, entry for Sotalol in each of the forms: Tablet containing sotalol hydrochloride 80 mg; and Tablet containing sotalol hydrochloride 160 mg
     omit:
         a  APO-Sotalol  TX  MP NP  C5664     60  5  60

     [91]               Schedule 1, Part 1, entry for Temozolomide in the form Capsule 180 mg
         (a)           omit:
         a  Temodal  MK  MP        5  5  5

         (b)           omit:
         a  Temodal  MK  MP     P4897  15  2  5

     [92]               Schedule 1, Part 1, entry for Temozolomide in the form Capsule 250 mg
     omit:
         a  Temodal  MK  MP        5  5  5

     [93]               Schedule 1, Part 1, entry for Tocilizumab in the form Injection 162 mg in 0.9 mL single use pre-filled syringe [Maximum Quantity: 4; Number of Repeats: 6]
omit from the column headed "Circumstances" (second instance only): C14195

     [94]               Schedule 1, Part 1, entry for Triglycerides, medium chain
     omit:
   Oral liquid 225 mL, 15 (K.Quik)  Oral     K.Quik  VF  MP NP  C6147 C6191     2  5  1

     [95]               Schedule 1, Part 1, entry for Triglycerides - medium chain, formula
     omit:
   Sachets containing oral powder 16 g, 30 (MCT Pro-Cal)  Oral     MCT Pro-Cal  VF  MP NP  C6136 C6156 C6165 C6173 C6192     4